This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CialisA® (tadalafil) Marks 10 Years Since U.S. Approval

INDIANAPOLIS, Nov. 18, 2013 /PRNewswire/ -- Cialis is turning 10. As Cialis marks its 10 th anniversary this week, Lilly is looking back on the last decade in men's health.

Conversations that used to be taboo for men are now taking place in bedrooms and exam rooms. Men with conditions like erectile dysfunction (ED) are talking more openly with their partners and their physicians. 1 Part of this evolution was the U.S. approval of Cialis for use as needed (5 mg, 10 mg, and 20 mg) on November 21, 2003, as the first and only oral ED medication that can work for up to 36 hours.* In the time since, Cialis has grown to become global share-of-market leader in sales among PDE5 inhibitors. 2

"Witnessing the evolution of Cialis since it entered the market 10 years ago, and the positive effects it continues to have on the treatment of erectile dysfunction, has been exciting," said Dr. Edward Kim, urologist, The University of Tennessee Medical Center. "Many of my patients have commented that the 36-hour dose and the daily dosing option have enabled them to become intimate without worrying about timing sexual activity around taking a pill.  As an investigator and prescribing physician, I have been fortunate to participate, first-hand, in the evolution and development of this noteworthy pill for the treatment of ED."

It is important to note that Cialis is not to be taken with medicines called "nitrates" such as isosorbide dinitrate or isosorbide mononitrate, which are often prescribed for chest pain; or with recreational drugs called "poppers" like amyl or butyl nitrite, as the combination may cause an unsafe drop in blood pressure.

Since that first FDA approval, Cialis has been approved for once-daily use (2.5, 5 mg,) for ED, and for the signs and symptoms of  benign prostatic hyperplasia (BPH), offering men the first and only single treatment option for two common urological conditions – ED and the signs and symptoms of BPH (Cialis 5 mg for once daily use).

1 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs